RESUMEN
OBJECTIVES: The aims of this study were: to determine the incidence of concurrent infections on a serovar level; to determine the incidence of multiple anatomical infected sites on a detection and genotyping level and analyse site-specific serovar distribution; to identify tissue tropism in urogenital versus rectal specimens. METHODS: Chlamydia trachomatis-infected patients in two populations were analysed: 75 visiting the outpatient department of obstetrics and gynaecology of the MC Haaglanden, and 358 visiting the outpatient sexually transmitted disease clinic, The Hague, The Netherlands. The PACE 2 assay (Gen-Probe) was used to detect C trachomatis from urethral, cervical, vaginal, oropharyngeal and anorectal swabs. C trachomatis genotyping was performed on all C trachomatis positive samples, using the CT-DT genotyping assay. RESULTS: Samples from 433 patients (256 female and 177 male) with confirmed C trachomatis infection were analysed. In 11 patients (2.6%), concurrent serovars in one anatomical sample site were present. In 62 (34.1%) female and four (9.3%) male patients, multiple sample site infections were found. A substantial percentage of women tested at the cervical/vaginal and rectal site were found to be positive at both sites (36.1%, 22/61). In men, D/Da and G/Ga serovars were more prevalent in rectal than urogenital specimens (p=0.0081 and p=0.0033, respectively), while serovar E was more prevalent in urogenital specimens (p=0.0012). CONCLUSIONS: The prevalence of multiple serovar infections is relatively low. Significant differences in serovar distribution are found in rectal specimens from men, with serovar G/Ga being the most prominent, suggesting tissue tropism.
Asunto(s)
Infecciones por Chlamydia/complicaciones , Chlamydia trachomatis/clasificación , Enfermedades del Recto/complicaciones , Adolescente , Adulto , Anciano , Infecciones por Chlamydia/epidemiología , Femenino , Amplificación de Genes , Genotipo , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Prevalencia , Enfermedades del Recto/epidemiología , Serotipificación/métodos , Adulto JovenRESUMEN
Chlamydia trachomatis serovars are divided into three serogroups, namely serogroup B, serogroup I (Intermediate) and serogroup C, and subsequently into 19 different serovars. Worldwide, serogroup B is the most prevalent followed by serogroup I. Clear differences have been observed in the duration of infection and growth kinetics between serovars from different serogroups in murine and cell culture models. Reasons for these observed differences are bacterial and host related, and are not well understood. The aim of this study was to determine the differences in immunoglobulin (Ig) G responses between the three serogroups in a group of patients infected with different serovars. Serovars were assessed from 235 C. trachomatispositive patients and quantitative IgG responses were determined. Analyses of variance were used to compare the IgG responses between the three serogroups. Of the serovars, 46% were B group (with serovar E the most prevalent: 35.3%), 39.6% were I group and 14.3% were C group. A highly significant difference in serologic response was shown when comparing the mean IgG concentrations (AU/mL) of patients having serovars in the most prevalent serogroup compared to the other serogroups: B = 135, C = 46 and I = 60 (B vs. C and B vs. I, P < 0.001). In conclusion, the most prevalent serovars generate the highest serologic responses.
Asunto(s)
Chlamydia trachomatis/inmunología , Anticuerpos Antibacterianos/sangre , Chlamydia trachomatis/clasificación , Femenino , Humanos , Inmunoglobulina G/sangre , SerotipificaciónRESUMEN
The use of an integrated approach to the study of Chlamydia trachomatis infection of the female genital tract, presented at the mini-symposium "Chlamydia trachomatis infections" and described in the thesis of Joseph M. Lyons, has resulted in the creation of the ICTI consortium. The ICTI consortium is based on strong interaction and collaboration between basic scientists, clinicians, epidemiologists, and health care policy makers. This translational approach will help to further the valuable insight into the immunopathogenesis of this sexually transmitted infection (STI) and the development of new intervention strategies, including the vaccines and screening programs necessary to effectively diagnose, treat and prevent C. trachomatis infection. A background of the need for this integrated approach is presented and the goals and participants of the consortium are described.
Asunto(s)
Infecciones por Chlamydia , Chlamydia trachomatis/patogenicidad , Enfermedades de los Genitales Femeninos/microbiología , Animales , Infecciones por Chlamydia/tratamiento farmacológico , Infecciones por Chlamydia/inmunología , Infecciones por Chlamydia/fisiopatología , Modelos Animales de Enfermedad , Femenino , Enfermedades de los Genitales Femeninos/inmunología , Enfermedades de los Genitales Femeninos/fisiopatología , Humanos , RatonesRESUMEN
BACKGROUND: A multicentre randomized controlled trial with or without hysterosalpingography (HSG) was conducted to assess the usefulness of HSG as a routine investigation in the fertility workup prior to laparoscopy and dye. METHODS: From 1 April 1997 to 1 April 2002, subfertile women were allocated by a computer-based 1 : 1 ratio randomization procedure, either for an HSG followed by laparoscopy and dye (the intervention group) of for laparoscopy and dye only (the control group) as a part of their fertility workup. Cumulative pregnancy rate (CPR) within 18 months after randomization was the primary outcome of interest. RESULTS: 344 women were randomized to the intervention group (n = 169) and the control group (n = 175). There was no significant difference in CPR at 18 months in the intervention group (49.1%) [95% confidence interval (CI) 41.6 to 56.6] and the control group (50.3%) (95% CI 42.8 to 57.8), a difference of -1.2% (95% CI -11.8% to 9.5%). CONCLUSION: The routine use of HSG at an early stage in the fertility workup prior to laparoscopy and dye does not influence CPR, compared with the routine use of laparoscopy and dye without HSG.
Asunto(s)
Enfermedades de las Trompas Uterinas/diagnóstico , Histerosalpingografía , Infertilidad Femenina/diagnóstico , Índice de Embarazo , Adulto , Enfermedades de las Trompas Uterinas/cirugía , Femenino , Humanos , Infertilidad Femenina/cirugía , Laparoscopía , EmbarazoRESUMEN
New serological enzyme immunoassays (EIAs) were compared with microimmunofluorescence (MIF) as a "gold standard" to detect Chlamydia trachomatis antibodies in different groups of obstetrical, gynecological, and subfertile patients. There were no significant differences in seroprevalence rates, except for the group of C. trachomatis-positive patients (P < 0.01). Test characteristics were calculated for Chlamydia-EIA (Biologische Analysensystem GmbH, Lich, Germany) and pELISA (Medac, Wedel, Germany). pELISA seems to be a good alternative to MIF. It has high specificity and is easier to perform.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Infecciones por Chlamydia/diagnóstico , Chlamydia trachomatis/inmunología , Infertilidad/microbiología , Pruebas Serológicas/métodos , Femenino , Fertilidad , Humanos , Inmunoensayo/métodos , Inmunoensayo/normas , Embarazo , Prevalencia , Sensibilidad y Especificidad , Pruebas Serológicas/normasRESUMEN
We report two patients with endometriosis of the rectovaginal septum in whom endovaginal ultrasound (US) and magnetic resonance imaging (MRI) played crucial roles in the diagnosis, staging, and follow-up of the disease. The specific features of endometriosis of the rectovaginal septum on MRI and transvaginal US enable a noninvasive diagnosis, thereby reducing diagnostic delay and avoiding unnecessary invasive procedures.
Asunto(s)
Endometriosis/diagnóstico por imagen , Endometriosis/diagnóstico , Enfermedades del Recto/diagnóstico por imagen , Enfermedades del Recto/diagnóstico , Enfermedades Vaginales/diagnóstico por imagen , Enfermedades Vaginales/diagnóstico , Adulto , Femenino , Humanos , Imagen por Resonancia Magnética , Ultrasonografía/métodosRESUMEN
OBJECTIVE: Evaluation of prevalence and risk factors of Chlamydia trachomatis infections in an outpatient obstetric and gynaecological population. METHODS: A prospective, observational study was performed at an inner city hospital in The Hague, Netherlands. 1368 women attending the outpatient department of obstetrics and gynaecology participated in the study. For detection of C trachomatis infections we used amplification of CT rRNA in urine samples (Gen Probe/AMPLIFIED-CT) and DNA probe for detection of CT rRNA from a urethral, endocervical and anal swab (Gen Probe/PACE 2). RESULTS: The overall prevalence of C trachomatis infections in our general obstetric and gynaecological population was 4.5%. The prevalence in women under 30 years of age was 8. 1%. We found age and postcoital bleeding to be significant risk factors. We did not find significant differences between women from different ethnic origin or between women using different kinds of contraceptives. 12 (19.4%) patients with C trachomatis infections were found positive by urine test only, and 15 (24.2%) only by DNA probe. CONCLUSIONS: Age is the most important risk factor in our population (overall prevalence 4.5%, prevalence in women under 20 years of age 15.8%). Analyses of urine and of endocervical specimens are complementary for the determination of the prevalence of C trachomatis infections in women. Cost effectiveness analysis is needed to determine to what extent age based screening and/or antibiotic prophylaxis before intrauterine manipulations is indicated.
Asunto(s)
Infecciones por Chlamydia/epidemiología , Chlamydia trachomatis , Adulto , Anciano , Anciano de 80 o más Años , Infecciones por Chlamydia/diagnóstico , Chlamydia trachomatis/genética , Femenino , Humanos , Modelos Logísticos , Persona de Mediana Edad , Países Bajos/epidemiología , Técnicas de Amplificación de Ácido Nucleico/métodos , Prevalencia , ARN Viral/análisisRESUMEN
Three women, aged 27, 32 and 30 years, respectively, suffered from headache, nausea and neurological abnormalities and were found to have an intracranial arteriovenous malformation (AVM). One of them after diagnosis had two pregnancies, both ended by caesarean section with good results. Another woman was 32 weeks pregnant when the AVM manifested itself with a haemorrhage; she recovered well and was delivered by caesarean section. After the AVM proved radiologically to have been obliterated, she delivered after her subsequent pregnancy by the vaginal route with vacuum extraction. The third woman was 15 weeks pregnant when major abnormalities developed. There was a large intracerebral haematoma with break-through to the ventricular system; this patient died. Intracranial haemorrhage during pregnancy is rate. It can result in maternal and foetal morbidity and mortality. It appears that pregnancy does not increase the rate of first cerebral haemorrhage from an AVM. The management of AVM rupture during pregnancy should be based primarily on neurosurgical rather than on obstetric considerations. Close collaboration with a team of neurologists, neurosurgeons, obstetricians and anaesthesiologists is mandatory.
Asunto(s)
Aneurisma Roto/diagnóstico , Malformaciones Arteriovenosas Intracraneales/diagnóstico , Complicaciones Cardiovasculares del Embarazo/diagnóstico , Adulto , Aneurisma Roto/complicaciones , Hemorragia Cerebral/etiología , Cesárea/efectos adversos , Resultado Fatal , Femenino , Cefalea/etiología , Humanos , Malformaciones Arteriovenosas Intracraneales/complicaciones , Malformaciones Arteriovenosas Intracraneales/terapia , Imagen por Resonancia Magnética , Náusea/etiología , Examen Neurológico , Embarazo , Complicaciones Cardiovasculares del Embarazo/terapia , Tomografía Computarizada por Rayos XRESUMEN
A survey is given on the literature of the prevention of adhesions. Various methods of adhesion prevention are discussed: limitation of peritoneal injury, inhibition of the inflammatory response, prevention of coagulation of fibrinogen, removal of fibrin and mechanical separation of injured mesothelial surfaces.
Asunto(s)
Enfermedades Peritoneales/prevención & control , Adherencias Tisulares/prevención & control , Abdomen/cirugía , Animales , Anticoagulantes/uso terapéutico , Femenino , Fibrinólisis , Humanos , Inflamación/prevención & control , Complicaciones Posoperatorias/prevención & control , Procedimientos Quirúrgicos Operativos/métodosRESUMEN
Symphysiotomy in a case of severe shoulder dystocia resulted in a successful vaginal delivery. Maternal morbidity, however, was considerable.
Asunto(s)
Distocia/cirugía , Hombro , Sinfisiotomía , Adulto , Femenino , Humanos , EmbarazoRESUMEN
The purpose of this study was to investigate differences in fibrinolytic activity in peritoneal fluid and plasma of women in the first and second part of the menstrual cycle. Given the classic concept of decreased fibrinolytic activity as a cause of adhesion formation, and if such differences are found, the stage of women's menstrual cycle should be taken into consideration when scheduling a laparotomy. We measured fibrinolytic parameters in peritoneal fluid and plasma in eight women in the pre-ovulatory period and in eleven women in the post-ovulatory period of the menstrual cycle. There were no differences in t-PA-Ag, t-PA-Act, u-PA-Ag and scu-PA concentrations in peritoneal fluid between the pre- and post-ovulatory group. Nevertheless, PAI-1-Ag in peritoneal fluid was three-fold higher in the post-ovulatory phase (p < 0.02). In peritoneal fluid the concentrations of both TDP and FbDP were three-fold higher at the same phase (p < or = 0.05). Plasma u-PA-Ag and scu-PA concentrations were significantly lower (30%, p < 0.05) in the post-ovulatory phase and also lower than plasma u-PA-Ag and scu-PA (measured with the same assay) in a group of 50 healthy individuals. No differences in t-PA and PAI concentration were found. In conclusion, the intraperitoneal fibrinolytic capacity might be impaired in the second part of the menstrual cycle, regarding the elevated levels of PAI-1-Ag, leading to an increased risk for post-ovulatory adhesion formation. The low plasma u-PA-Ag and scu-PA levels post-ovulatory may have clinical relevance.
Asunto(s)
Líquido Ascítico , Fibrinólisis , Laparotomía/efectos adversos , Ciclo Menstrual/fisiología , Activadores Plasminogénicos/análisis , Adherencias Tisulares/prevención & control , Adulto , Estradiol/sangre , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Humanos , Ovulación , Activadores Plasminogénicos/sangre , Adherencias Tisulares/fisiopatologíaRESUMEN
Previous studies have shown that the fibrinolytic activity of peritoneum is depressed in local inflammation. We measured fibrinolytic parameters in peritoneal fluid and in plasma of 10 women with pelvic inflammatory disease (PID). Nine women, in whom laparoscopy for sterilisation was performed, served as a control group. In the peritoneal fluid of women with PID, PAI-Ag, t-PA-Ag and u-PA-Ag were many times higher than in the control group. In contrast to the antigens which may be present in inert complexes, the potentially active compounds, measured as t-PA activity and plasmin-activable scu-PA, were not significantly different in the two groups, and in none of the samples was the active enzyme tcu-PA detectable. Nevertheless, the mean peritoneal fluid TDP and FbDP concentrations were about twenty times higher in the PID group than in the control group. In plasma of PID patients, none of the parameters except u-PA-Ag differed from those in the control group. The difference between control and patient plasma u-PA-Ag was statistically significant, but too small to attach any relevance to the observation. Our data suggest that, in contrast to the classical concept of decreased fibrinolytic activity as a cause of adhesion formation, intraperitoneal fibrinolysis is enhanced in peritoneal inflammation through stimulation of the local production of t-PA and u-PA. Despite concomitant production of PAI, fibrinolysis occurs at a high rate, resulting in high levels of fibrin degradation products. Since this activated fibrinolysis does not meet the demand, therapeutic enhancement should be considered to prevent adhesions.
Asunto(s)
Fibrinólisis , Enfermedad Inflamatoria Pélvica/metabolismo , Adolescente , Adulto , Líquido Ascítico/metabolismo , Femenino , Fibrina/metabolismo , Productos de Degradación de Fibrina-Fibrinógeno/metabolismo , Humanos , Enfermedad Inflamatoria Pélvica/sangre , Inactivadores Plasminogénicos/metabolismo , Activador de Tejido Plasminógeno/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/metabolismoRESUMEN
The fibrinolytic system of the peritoneum is important in the pathogenesis of adhesions. Plasminogen activator activity is depressed by serosal types of injury, which cause ischemia. Ischemic peritoneum induces fibrinous adhesions. When local fibrinolytic activity is impaired, persistence of fibrin and organisation of the fibrinous adhesions may occur. Peritoneal adhesion in rabbits were created by drying the serosa of the uterine horns and by introducing a small amount of blood intraperitoneally. In one group of rabbits tissue-type plasminogen activator (t-PA) was given intraperitoneally at the end of the operation: another group served as controls. 48 rabbits were operated on. The animals were killed 3 h, 1, 3 and 7 days postoperatively for evaluation of adhesions. All animals of the control group had adhesions. The animals of the t-PA group had less adhesions than the animals of the control group.